-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Pro-Dex (NASDAQ:PDEX) Shares Cross Above 200 Day Moving Average of $17.27
Pro-Dex (NASDAQ:PDEX) Shares Cross Above 200 Day Moving Average of $17.27
Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating)'s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $17.27 and traded as high as $17.99. Pro-Dex shares last traded at $17.48, with a volume of 2,397 shares.
Wall Street Analyst Weigh In
Separately, StockNews.com began coverage on Pro-Dex in a report on Wednesday, December 7th. They set a "hold" rating for the company.
Get Pro-Dex alerts:Pro-Dex Stock Performance
The firm has a market capitalization of $62.58 million, a price-to-earnings ratio of 16.81 and a beta of 0.91. The company has a fifty day moving average of $18.11 and a two-hundred day moving average of $17.27. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.39 and a current ratio of 2.73.
Institutional Trading of Pro-Dex
Several hedge funds have recently added to or reduced their stakes in PDEX. Tower Research Capital LLC TRC raised its holdings in Pro-Dex by 345.6% in the 3rd quarter. Tower Research Capital LLC TRC now owns 2,687 shares of the medical instruments supplier's stock valued at $48,000 after acquiring an additional 2,084 shares in the last quarter. Renaissance Technologies LLC acquired a new position in Pro-Dex in the 2nd quarter valued at $168,000. State Street Corp raised its holdings in Pro-Dex by 5.8% in the 1st quarter. State Street Corp now owns 11,923 shares of the medical instruments supplier's stock valued at $197,000 after acquiring an additional 650 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Pro-Dex by 59.2% in the 1st quarter. JPMorgan Chase & Co. now owns 20,863 shares of the medical instruments supplier's stock valued at $345,000 after acquiring an additional 7,762 shares in the last quarter. Finally, LSV Asset Management raised its holdings in Pro-Dex by 13.9% in the 1st quarter. LSV Asset Management now owns 35,581 shares of the medical instruments supplier's stock valued at $588,000 after acquiring an additional 4,346 shares in the last quarter. 13.69% of the stock is owned by institutional investors and hedge funds.Pro-Dex Company Profile
(Get Rating)
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Featured Articles
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- 3 Mid-Caps That Could Double in 2023
- Mullen Automotive Shares Jump After Signing New Partner
- REV Group Leads Specialty Vehicle Manufacturers Higher
- NVIDIA vs AMD: Which is better for 2023?
- Can FDA Approval Bolster DexCom, Inc.?
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating)'s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $17.27 and traded as high as $17.99. Pro-Dex shares last traded at $17.48, with a volume of 2,397 shares.
在周三的交易中，Pro-Dex，Inc.(纳斯达克代码：PDEX-GET Rating)的股价突破了200日移动均线切入位17.27美元，最高交易价格为17.99美元。Pro-Dex的股票最新报17.48美元，成交量为2,397股。
Wall Street Analyst Weigh In
华尔街分析师也加入进来
Separately, StockNews.com began coverage on Pro-Dex in a report on Wednesday, December 7th. They set a "hold" rating for the company.
另外，StockNews.com在12月7日星期三的一份报告中开始报道Pro-Dex。他们为该公司设定了“持有”评级。
Pro-Dex Stock Performance
Pro-Dex股票表现
The firm has a market capitalization of $62.58 million, a price-to-earnings ratio of 16.81 and a beta of 0.91. The company has a fifty day moving average of $18.11 and a two-hundred day moving average of $17.27. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.39 and a current ratio of 2.73.
该公司市值为6258万美元，市盈率为16.81倍，贝塔系数为0.91。该公司的50日移动均线切入位在18.11美元，200日移动均线切入位在17.27美元。该公司的负债权益比率为0.41，速动比率为1.39，流动比率为2.73。
Institutional Trading of Pro-Dex
Pro-Dex的机构交易
Pro-Dex Company Profile
Pro-Dex公司简介
(Get Rating)
(获取评级)
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Pro-Dex公司为世界各地的医疗器械原始设备制造商设计、开发、制造和销售动力手术器械。该公司提供可高压灭菌、电池供电和电动的多功能外科驱动程序和剃须刀，主要用于整形外科、胸部和颅颌面部市场。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- 3 Mid-Caps That Could Double in 2023
- Mullen Automotive Shares Jump After Signing New Partner
- REV Group Leads Specialty Vehicle Manufacturers Higher
- NVIDIA vs AMD: Which is better for 2023?
- Can FDA Approval Bolster DexCom, Inc.?
- 免费获取StockNews.com Pro-Dex上的研究报告(PDEX)
- 2023年中型股可能翻一番
- 马伦汽车签署新合作伙伴后股价上涨
- REV集团引领专用车制造商走高
- NVIDIA VS AMD：2023年哪一种更好？
- FDA的批准能支持DexCom，Inc.吗？
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
接受Pro-Dex Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Pro-Dex和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧